Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

OrganiGram Holdings Inc. (T:OGI)

Business Focus: Medical Farming

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for OGI within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jan 11, 2022 06:00 ET
Organigram Reports First Quarter Fiscal 2022 Results
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended November 30, 2021 (“Q1 Fiscal 2022”).
Read full article
Jan 05, 2022 06:00 ET
Organigram to Report First Quarter Fiscal 2022 Results on January 11, 2022
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2022 ended November 30, 2021 on Tuesday, January 11, 2022 before market open.
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
1.12
--
--
Price to Sales - TTM
6.87
3.31
10.69
Price to Book - most recent quarter
1.29
1.52
2.52
Price to Cash Flow per share - TTM
--
0.17
13.73
Price to Free Cash Flow per share - TTM
--
--
28.71
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Dec 31, 20216,755,331-3,448,122
Dec 15, 202110,203,4531,052,614
Nov 30, 20219,150,839-1,170,071
See Short Report

Business Summary

Sector:  Healthcare Industry:  Healthcare Facilities & Services

OrganiGram Holdings Inc is a Canada-based company, which operates through its subsidiary, Organigram Inc (Organigram). Organigram is a licensed producer of cannabis and extract-based products. The Company is focused on producing, indoor-grown cannabis for patients and adult recreational consumers in Canada. Organigram is permitted to possess, produce, sell, provide, ship, deliver and transport cannabis, cannabis plants and cannabis oil. It is also authorized for wholesale shipping of cannabis plant cuttings, dried flower, blends, pre-rolls and cannabis oil to approved retailers and wholesalers for adult-use recreational cannabis under individual provincial and territorial regulations as per Cannabis Act. Organigram distributes its products mainly through the Company's online store or by phone. Organigram has also developed a portfolio of legal adult use recreational cannabis brands, including The Edison Cannabis Company, SHRED, ANKR Organics, Indi, Bag o' Buds and Trailblazer.

See business summary

 

Twitter

Search (past week) for $OGI.CA

  • No tweets found